Enzymatic quorum quenching increases antibiotic susceptibility of multidrug resistant Pseudomonas aeruginosa
Abstract
Background and Objectives: There is increasing emergence of multidrug resistant Pseudomonas aeruginosa (MDRPA) strains and drug resistance is positively-correlated with biofilm-forming ability. Since about 10% of P. aeruginosa genome is controlled by quorum sensing (QS), alteration in its antibiotic susceptibility by targeting QS was the focus of the present study.
Materials and Methods: One day biofilms of PAO1 and three urinary tract infection MDRPA isolates (PA2, PA8 and PA18) were formed in 96-well microtiter plate. Biofilms were exposed to concentration gradient of ciprofloxacin and gentamicin to obtain Minimum Biofilm Eradication Concentration (MBEC) by direct enumeration method. Susceptibility of 24 h biofilms was evaluated by treatment with ciprofloxacin and gentamicin per se and in combination with lactonase. The effect was also examined on 72 h biofilms by Scanning Electron Microscopy.
Results: Lactonase treatment did not have any effect on growth of the selected strains but 73.42, 69.1, 77.34 and 72.5% reduction of biofilm was observed after lactonase (1 unit) treatment, respectively. Antibiotics in combination with lactonase (0.3 units) resulted in an increased susceptibility of the biofilm forms by > 3.3, 4, 5 and 1.5 folds of MBEC, for ciprofloxacin and > 6.67, 12.5, 6 and > 2.5 folds, for gentamicin respectively, which could be due to the disruption of biofilm by lactonase treatment as shown by scanning electron microscopy. Also there was significant reduction (p < 0.001) in virulence factor production by the strains.
Conclusion: Lactonase treatment increased antibiotic susceptibility of the biofilms of MDRPA isolates underscoring the potential of quorum quenching in antimicrobial therapeutics.
Fricks-Lima J, Hendrickson CM, Allgaier M, Zhuo H, Wiener-Kronish JP, et al. Differences in biofilm formation and antimicrobial resistance of Pseudomonas aeruginosa isolated from airways of mechanically ventilated patients and cystic fibrosis patients. Int J Antimicrob Agents 2011; 37: 309-315.
O’Toole GA. Microtiter dish biofilm formation assay. J Vis Exp 2011; 47: 2437.
Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 2005; 11 17-32.
Zhuo H, Yang K, Lynch SV, Dotson RH, Glidden DV, Singh G, et al. Increased mortality of ventilated patients with endotracheal Pseudomonas aeruginosa without clinical signs of infection. Crit Care Med 2008; 36:2495-2503.
Dotsch A, Becker T, Pommerenke C, Magnowska Z, et al. Genomewide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009; 53:2522-2531.
Montero M, Domínguez M, Orozco-Levi M, Salvadó M, Knobel H. Mortality of COPD patients infected with multi-resistant Pseudomonas aeruginosa: a case and control study. Infection 2009; 37: 16-19.
Pena C, Suarez C, Tubau F, Dominguez A, Sora M, Pujol M, et al. Carbapenem-resistant Pseudomonas aeruginosa: factors influencing multidrug-resistant acquisition in non-critically ill patients. Eur J Clin Microbiol Infect Dis 2009; 28: 519-522.
Chang KC, Yew WW, Chan RC. Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2010; 65: 1551-1561.
Hassan A, Usman J, Kaleem F, Khan A, Hussain Z. In vitro activity of aminoglycosides, β lactam-β lactamases inhibitor combinations and tetracyclines against multi- drug resistant Acinetobacter baumannii, isolated from a tertiary care hospital. J Microbiol Antimicrob 2010;2: 47-50.
Davis MA, Baker KN, Orfe LH, Shah DH, Besser TE, Call DR. Discovery of a gene conferring multiple- aminoglycoside resistance in Escherichia coli. Antimicrob Agents Chemother 2010; 54: 2666-2669.
Macmaster R, Zelinskaya N, Savic M, Rankin CR, Conn GL. Structural insights into the function of aminoglycoside-resistance A1408 16S rRNA methyltransferases from antibiotic-producing and human pathogenic bacteria. Nucleic Acids Res 2010; 38:7791-7799.
Endimiani A, Hujer KM, Hujer AM, Armstrong ES, Choudhary Y, et al. ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates. Antimicrob Agents Chemother 2009; 53: 4504-4507.
Diggle SP, Crusz SA, Camara M. Quorum sensing. Curr Biol 2007; 17: R907-910.
Kohler T, Perron GG, Buckling A, van Delden C.Quorum sensing inhibition selects for virulence and cooperation in Pseudomonas aeruginosa. PLoS Pathog 2010; 6: e1000883.
Shaw PD, Ping G, Daly SL, Cha C, Cronan JE, Rinehart K, et al. Detecting and characterizing N-acyl-homoserine lactone signal molecules by thin-layer chromatography. Proc Natl Acad Sci (USA) 1997; 94: 6036-6041.
Sambrook J, Russell DW (2001). Molecular cloning: a laboratory manual. 3rd ed. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY.
Reimmann C, Ginet N, Michel L, Keel C, Michaux P, Krishnapillai V, et al. Genetically programmed autoinducer destruction reduces virulence gene expression and swarming motility in Pseudomonas aeruginosa PAO1. Microbiology 2002; 148: 923-932.
Thomas PW, Stone EM, Costello AL, Tierney DL, Fast W. The quorum-quenching lactonase from Bacillus thuringiensis is a metalloprotein. Biochemistry 2005; 4:7559-7569.
Martinez-Medina M, Naves P, Blanco J, Aldeguer X, Blanco JE, et al. Biofilm formation as a novel phenotypic feature of adherent-invasive Escherichia coli (AIEC). BMC Microbiol 2009; 9: 202-217.
Wouafo M, Nzouankeu A, Kinfack JA, Fonkoua MC, Ejenguele G, et al. Prevalence and antimicrobial resistance of Salmonella serotypes in chickens from retail markets in Yaounde (Cameroon). Microb Drug Resist 2010; 16: 171-176.
Engler KH, Coker RD, Evans IH. A colorimetric technique for detecting trichothecenes and assessing relative potencies. Appl Environ Microbiol 1999; 65: 1854-1857.
Deligianni E, Pattison S, Berrar D, Ternan NG, Haylock RW, et al. Pseudomonas aeruginosa cystic fibrosis isolates of similar RAPD genotype exhibit diversity in biofilm forming ability in vitro. BMC Microbiol 2010;10: 38.
Yadav V, Harjai K, Kaur R, Joshi K, Sharma S.Urovirulence of Pseudomonas aeruginosa: planktonic vs. biofilm cells. Folia Microbiologica 2004; 49: 465-470.
Chessa JP, Petrescu I, Bentahir M, Van Beeumen J, Gerday C. Purification, physico-chemical characterization and sequence of a heat labile alkaline metalloprotease isolated from a psychrophilic Pseudomonas species. Biochim Biophys Acta 2000; 1479: 265-274.
Visca P, Chiarini F, Mansi A, Vetriani C, Serino L, Orsi N. Virulence determinants in Pseudomonas aeruginosa strains from urinary tract infections. Epidem Infec 1992;108: 323–336.
Abdel-Mawgoud AM, Aboulwafa MM, Hassouna NA. Characterization of rhamnolipid produced by Pseudomonas aeruginosa isolate Bs20. Appl Biochem Biotechnol 2009; 157: 329-345.
Su HC, Ramkissoon K, Doolittle J, Clark M, Khatun J, Secrest A, et al. The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins. Antimicrob Agents Chemother 2010; 54: 4626-4635.
O’Fallon E, Schreiber R, Kandel R, D’Agata EM.Multidrug-resistant gram-negative bacteria at a long- term care facility: assessment of residents, healthcare workers, and inanimate surfaces. Infect Control Hosp Epidemiol 2009; 30: 1172-1179.
Talebi M, Pourshafie MR, Katouli M, Mollby R.Molecular structure and transferability of Tn1546-like elements in Enterococcus faecium isolates from clinical, sewage, and surface water samples in Iran. Appl Environ Microbiol 2008; 74: 1350-1356.
Breidenstein EB, Khaira BK, Wiegand I, Overhage J, Hancock RE. Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility. Antimicrob Agents Chemother 2008; 52: 4486-4491.
Schaber JA, Carty NL, McDonald NA, Graham ED, Cheluvappa R, et al. Analysis of quorum sensing- deficient clinical isolates of Pseudomonas aeruginosa. J Med Microbiol 2004; 53: 841-853.
Schipper C, Hornung C, Bijtenhoorn P, Quitschau M, Grond S, Streit WR. Metagenome-derived clones encoding two novel lactonase family proteins involved in biofilm inhibition in Pseudomonas aeruginosa. Appl Environ Microbiol 2009; 75: 224–233.
Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 2002; 184: 1140-1154.
Shih PC, Huang CT. Effects of quorum-sensing deficiency on Pseudomonas aeruginosa biofilm formation and antibiotic resistance. J Antimicrob Chemother 2002; 49: 309-14.
Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2000; 44: 1818–1824.
Carmen JC, Nelson JL, Beckstead BL, Runyan CM, Robison RA, et al. Ultrasonic-enhanced gentamicin transport through colony biofilms of Pseudomonas aeruginosa and Escherichia coli. J Infect Chemother 2004; 10: 193-199.
Rahmati S, Yang S, Davidson AL, Zechiedrich EL.Control of the AcrAB multidrug efflux pump by quorum-sensing regulator SdiA. Mol Microbiol 2002;43: 677-685.
Aendekerk S, Diggle SP, Song Z, Hoiby N, Cornelis P, et al. The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communication. Microbiology 2005; 151:1113-1125.
Ahmed NA, Petersen FC, Scheie AA. AI-2 quorum sensing affects antibiotic susceptibility in Streptococcus anginosus. J Antimicrob Chemother 2007; 60: 49-53.
Butler MT, Wang Q, Harshey RM. Cell density and mobility protect swarming bacteria against antibiotics. Proc Natl Acad Sci USA 2010; 107: 3776-3781.
Drago L, de Vecchi E, Nicola L., Tocalli L, Gismondo MR. Effect of moxifloxacin on bacterial pathogenicity factors in comparison with amoxicillin, clarithromycin and ceftriaxone. J Chemother 2004; 16: 30–37.
Wojnicz D, Kłak M, Adamski R, Jankowski S. Influence of sub-inhibitory concentrations of amikacin and influence colony and biofilm morphology. Appl Environ Microbiol 2009; 75: 45-53.
Rasmussen TB, Bjarnsholt T, Skindersoe ME, Hentzer M, Kristoffersen P, et al. Screening for quorum-sensing Inhibitors (QSI) by use of a novel genetic system, the QSI Selector. J Bacteriol 2005; 187: 1799-1814.
Nasr S, Soudi MR, Mehrnia MR, Sarrafzadeh MH.Characterization of novel biosurfactant producing strains of Bacillus spp. isolated from petroleum contaminated soil. Iran J Microbiol 2009; 1: 54-61.
Tarighi S, Wei Q, Cámara M, Williams P, et al. The PA4204 gene encodes a periplasmic gluconolactonase (PpgL) which is important for fitness of Pseudomonas aeruginosa. Microbiology 2008; 154: 2979-2990.
Tarighi S. Characterization of the fqsM gene (fitness and quorum sensing modulator) in Pseudomonas aeruginosa and P. syringae. International conference on Pseudomonas. 2007; 08: 26.
Tarighi S. PA4203, a novel regulator of fitness, quorum sensing and pyoverdine systems in Pseudomonas aeruginosa. 13th conference of the Belgian Society for Microbiology. 2007; 11: 23.
Tarighi S. The fqsM gene is important for fitness and quorum sensing in Pseudomonas syringae, 59th international symposium on crop protection. 2007; 05: 22.
Files | ||
Issue | Vol 3 No 1 (2011) | |
Section | Articles | |
Keywords | ||
Multidrug resistance Pseudomonas aeruginosa AHL Lactonase Biofilm Antibiotic Susceptibility antimicrobial therapeutics |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |